NCT02666963View on ClinicalTrials.gov

A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

July 23, 2017

Study Completion Date

July 23, 2017

Conditions
Healthy
Interventions
DRUG

RTA 901 Capsules, 10 or 40 mg

DRUG

Placebo

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY